Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
By optimizing sugar metabolism and providing the tools needed to maintain balance, Release WLP helps create the ideal environment for healthy, sustainable weight management
The 0.4 mg difference reflects the dose found optimal for weight loss in the STEP trials vs the dose found optimal for glycemic control in the SUSTAIN trials
Importantly, because GLP-1 receptor agonists work in a glucose-dependent manner, they generally carry a lower risk of hypoglycaemia compared to some other diabetes medications
On the other hand, FDA-approved medications, like Ozempic, Wegovy, and Rybelsus, are studied in extensive clinical trials involving real patients
GLP-1 (glucagon-like peptide-1) agonists work by mimicking a natural incretin hormone your body produces
